Valuation dashboard for Azenta, Inc. (AZTA) with P/E N/A, P/B 1.16, EV/EBITDA -14.87 and dividend yield 0.00%. DCF, Graham Number, EPS growth, peer multiples and dividend discount models plus sector comparison against other Healthcare companies.
Azenta, Inc. is a global leader specializing in advanced solutions for the discovery, handling, and preservation of life science samples. The company's operations span across North America, Europe, Asia Pacific (including China), and other international markets. Its business is structured into two main reportable segments: Life Sciences Products and Life Sciences Services.
Analysis Summary
Azenta, Inc. reported revenue of $593.8M in the most recent fiscal year, growing at a 5-year CAGR of 8.9%.
Trailing-twelve-month margins: gross margin 44.0%, operating margin -3.5%, net margin -20.0%.
At the current price of $42.73, AZTA has negative trailing earnings (P/E not meaningful) and an ROE of -7.56%. Market capitalisation stands at $2.0B.
Balance sheet quality for AZTA: current ratio of 3.0. A debt-to-equity below 1.0 typically signals conservative capital structure, while a current ratio above 1.5 indicates comfortable short-term liquidity.
Valuation Ratios
| Price / Book | 1.16 |
| EV / EBITDA | -14.87 |
| Dividend Yield | 0.00% |
Valuation Models
| DCF Fair Value | $10.85 |
| vs Current Price | -74.6% |
Peer Comparison
| Symbol | Company | Market Cap | P/E | P/B | ROE |
|---|---|---|---|---|---|
| AZTA | Azenta, Inc. | $1.8B | 1.16 | -7.6% | |
| NEOG | Neogen Corporation | $2.6B | 1.26 | -0.4% | |
| SDGR | Schrödinger, Inc. | $2.3B | 6.88 | -16.4% | |
| 0R29.L | Intuitive Surgical, Inc. | $147.8B | |||
| ISRG | Intuitive Surgical, Inc. | $138.5B | 44.59 | 7.65 | 16.0% |
| 0R19.L | Becton, Dickinson and Company | $51.8B | 54.42 | 2.03 | 3.8% |
| BDX | Becton, Dickinson and Company | $48.7B | 53.25 | 1.99 | 6.6% |
| RMD | ResMed Inc. | $31.8B | 21.05 | 4.81 | 23.1% |
Price
| Price | $42.73 |
| Market Cap | $2.0B |
| Exchange | NASDAQ |
| Country | US |
Profitability
| Return on Equity | -7.56% |
| Return on Invested Capital | -1.01% |
| Return on Assets | -6.55% |
| Gross Margin | 44.05% |
| Operating Margin | -3.49% |
| Net Margin | -20.02% |
Related companies: BLFS · ESTA · EVO · KMTS · NEOG · NVCR · SDGR
Explore sector: Healthcare · Medical - Instruments & Supplies
More sections of AZTA: Overview · Financials · Statistics · Estimates · Technical · Ownership · News · Events
Discover more: Weekly Radar: the S&P 500 through the Buffett and Lynch methods · Investment Academy — learn to analyze stocks